drugset / Trial / NCT02173132

Acetyl-L-Carnitine Reduces Perceived Work Stress and Improves Work Ability and Work Performance in Hepatic Encephalopathy

NCT02173132

Phase 3 Completed 94 enrolled University of Catania
RandomizedParallel-groupDouble-blindTreatment

Summary

This study evaluated the effects of acetyl-L-carnitine treatment on Perceived Work Stress, Work Ability and Work Performance in subjects with Hepatic Encephalopathy.

Timeline

Start
2010-04
Primary completion
2013-11
Completion

Drugs

EvaluationDrugModalityDoseRoute
Comparator Acetylcarnitine Small molecule 2 g